240 related articles for article (PubMed ID: 11427888)
1. Structure of GSK3beta reveals a primed phosphorylation mechanism.
ter Haar E; Coll JT; Austen DA; Hsiao HM; Swenson L; Jain J
Nat Struct Biol; 2001 Jul; 8(7):593-6. PubMed ID: 11427888
[TBL] [Abstract][Full Text] [Related]
2. The structure of phosphorylated GSK-3beta complexed with a peptide, FRATtide, that inhibits beta-catenin phosphorylation.
Bax B; Carter PS; Lewis C; Guy AR; Bridges A; Tanner R; Pettman G; Mannix C; Culbert AA; Brown MJ; Smith DG; Reith AD
Structure; 2001 Dec; 9(12):1143-52. PubMed ID: 11738041
[TBL] [Abstract][Full Text] [Related]
3. The structural basis for specificity of substrate and recruitment peptides for cyclin-dependent kinases.
Brown NR; Noble ME; Endicott JA; Johnson LN
Nat Cell Biol; 1999 Nov; 1(7):438-43. PubMed ID: 10559988
[TBL] [Abstract][Full Text] [Related]
4. Atomic structure of the MAP kinase ERK2 at 2.3 A resolution.
Zhang F; Strand A; Robbins D; Cobb MH; Goldsmith EJ
Nature; 1994 Feb; 367(6465):704-11. PubMed ID: 8107865
[TBL] [Abstract][Full Text] [Related]
5. Crystal structure of PTP-SL/PTPBR7 catalytic domain: implications for MAP kinase regulation.
Szedlacsek SE; Aricescu AR; Fulga TA; Renault L; Scheidig AJ
J Mol Biol; 2001 Aug; 311(3):557-68. PubMed ID: 11493009
[TBL] [Abstract][Full Text] [Related]
6. Glycogen synthase kinase 3beta is tyrosine phosphorylated by PYK2.
Hartigan JA; Xiong WC; Johnson GV
Biochem Biophys Res Commun; 2001 Jun; 284(2):485-9. PubMed ID: 11394906
[TBL] [Abstract][Full Text] [Related]
7. Signalling specificity of Ser/Thr protein kinases through docking-site-mediated interactions.
Biondi RM; Nebreda AR
Biochem J; 2003 May; 372(Pt 1):1-13. PubMed ID: 12600273
[TBL] [Abstract][Full Text] [Related]
8. The structure of Sky1p reveals a novel mechanism for constitutive activity.
Nolen B; Yun CY; Wong CF; McCammon JA; Fu XD; Ghosh G
Nat Struct Biol; 2001 Feb; 8(2):176-83. PubMed ID: 11175909
[TBL] [Abstract][Full Text] [Related]
9. Picture story. Reining in CDK.
Feng H
Nat Struct Biol; 2001 May; 8(5):391. PubMed ID: 11323710
[No Abstract] [Full Text] [Related]
10. Discovery and characterization of a substrate selective p38alpha inhibitor.
Davidson W; Frego L; Peet GW; Kroe RR; Labadia ME; Lukas SM; Snow RJ; Jakes S; Grygon CA; Pargellis C; Werneburg BG
Biochemistry; 2004 Sep; 43(37):11658-71. PubMed ID: 15362850
[TBL] [Abstract][Full Text] [Related]
11. Protein kinase substrate recognition studied using the recombinant catalytic domain of AMP-activated protein kinase and a model substrate.
Scott JW; Norman DG; Hawley SA; Kontogiannis L; Hardie DG
J Mol Biol; 2002 Mar; 317(2):309-23. PubMed ID: 11902845
[TBL] [Abstract][Full Text] [Related]
12. Structure of the autoinhibited kinase domain of CaMKII and SAXS analysis of the holoenzyme.
Rosenberg OS; Deindl S; Sung RJ; Nairn AC; Kuriyan J
Cell; 2005 Dec; 123(5):849-60. PubMed ID: 16325579
[TBL] [Abstract][Full Text] [Related]
13. A structural basis for substrate specificities of protein Ser/Thr kinases: primary sequence preference of casein kinases I and II, NIMA, phosphorylase kinase, calmodulin-dependent kinase II, CDK5, and Erk1.
Songyang Z; Lu KP; Kwon YT; Tsai LH; Filhol O; Cochet C; Brickey DA; Soderling TR; Bartleson C; Graves DJ; DeMaggio AJ; Hoekstra MF; Blenis J; Hunter T; Cantley LC
Mol Cell Biol; 1996 Nov; 16(11):6486-93. PubMed ID: 8887677
[TBL] [Abstract][Full Text] [Related]
14. Crystal structure of an activated Akt/protein kinase B ternary complex with GSK3-peptide and AMP-PNP.
Yang J; Cron P; Good VM; Thompson V; Hemmings BA; Barford D
Nat Struct Biol; 2002 Dec; 9(12):940-4. PubMed ID: 12434148
[TBL] [Abstract][Full Text] [Related]
15. Molecular modeling and molecular dynamics simulation studies of the GSK3β/ATP/substrate complex: understanding the unique P+4 primed phosphorylation specificity for GSK3β substrates.
Lu SY; Jiang YJ; Zou JW; Wu TX
J Chem Inf Model; 2011 May; 51(5):1025-36. PubMed ID: 21495724
[TBL] [Abstract][Full Text] [Related]
16. The structure of MSK1 reveals a novel autoinhibitory conformation for a dual kinase protein.
Smith KJ; Carter PS; Bridges A; Horrocks P; Lewis C; Pettman G; Clarke A; Brown M; Hughes J; Wilkinson M; Bax B; Reith A
Structure; 2004 Jun; 12(6):1067-77. PubMed ID: 15274926
[TBL] [Abstract][Full Text] [Related]
17. Crystal structure of glycogen synthase kinase 3 beta: structural basis for phosphate-primed substrate specificity and autoinhibition.
Dajani R; Fraser E; Roe SM; Young N; Good V; Dale TC; Pearl LH
Cell; 2001 Jun; 105(6):721-32. PubMed ID: 11440715
[TBL] [Abstract][Full Text] [Related]
18. The third conformation of p38α MAP kinase observed in phosphorylated p38α and in solution.
Akella R; Min X; Wu Q; Gardner KH; Goldsmith EJ
Structure; 2010 Dec; 18(12):1571-8. PubMed ID: 21134636
[TBL] [Abstract][Full Text] [Related]
19. The mechanism of inhibition of the cyclin-dependent kinase-2 as revealed by the molecular dynamics study on the complex CDK2 with the peptide substrate HHASPRK.
Bártová I; Otyepka M; Kríz Z; Koca J
Protein Sci; 2005 Feb; 14(2):445-51. PubMed ID: 15632290
[TBL] [Abstract][Full Text] [Related]
20. The structure of phosphorylated p38gamma is monomeric and reveals a conserved activation-loop conformation.
Bellon S; Fitzgibbon MJ; Fox T; Hsiao HM; Wilson KP
Structure; 1999 Sep; 7(9):1057-65. PubMed ID: 10508788
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
